Brian Fiske, chief scientist at The Michael J. Fox Foundation for Parkinson’s Research, which funded some of Dr ...

Penn State Health Milton S. Hershey Medical Center is Pennsylvania's first hospital to offer BrainSense adaptive deep brain stimulation for Parkinson’s Disease.

Curonix LLC, a leading medical technology company specializing in relieving chronic pain without the use of opioids, proudly introduces NervPulse™ Therapy, an advanced, evidence-based programming ...

Twenty-eight years later, as a political science professor emeritus at Stanford, Krehbiel just became the first person in the ...

With its FDA-approved neurostimulator implant aimed at helping patients recover from stroke, MicroTransponder has raised $65 million in venture capital funding to expand its commercial reach.

Cortigent’s Orion ® artificial vision system, which is in development to treat blindness, completed an initial 6-year clinical study in 2024, with encouraging safety and efficacy results ...

Orion system completed a 6-year Early Feasibility Study in 2024 with positive safety and efficacy results. Spin-off is expected to be finalized by or before Q3 2025. With stocks plunging, steady ...

These include cables for daily heart rate monitors and ultra-thin wires for neurostimulator implants and cardiac pacemakers.